Role of peritoneal lavage cytology and prediction of prognosis and peritoneal recurrence after curative surgery for colorectal cancer

Annals of Coloproctology

Volumn 30, Issue 6, 2014, Pages 266-273

  Bae, Sung Joon ^a   Shin, Ui Sup ^a   Ki, Young Jun ^a   Cho, Sang Sik ^a   Moon, Sun Mi ^a   Park, Sun Hoo ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

Colorectal neoplasms; Cytology; Peritoneal metastasis; Prognosis; Survival

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; OXALIPLATIN; PERITONEAL DIALYSIS FLUID;

ADULT; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PERINEURAL INVASION; PERITONEUM LAVAGE; PROSPECTIVE STUDY; TUMOR PERFORATION;

EID: 84925745887     PISSN: 22879714     EISSN: 22879722     Source Type: Journal    
DOI: 10.3393/ac.2014.30.6.266     Document Type: Article

References (30)

1. Kanas G P, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. Survival after liver resection in metastatic colorec-tal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 2012; 4: 283-301.
2. Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol 2013; 20: 572-9.
3. Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Mahoney MR, O'Neil BH, et al. CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leu-covorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients with KRAS wild-type untreated metastatic ade-nocarcinoma of the colon or rectum [abstract]. In: 2014 American Society of Clinical Oncology Annual Meeting; 2014 May 30 - June 3; Chicago, USA. Alexandria (VA): American Society of Clinical Oncology; 2014.
4. Kerscher AG, Chua TC, Gasser M, Maeder U, Kunzmann V, Isbert C, et al. Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades. Br J Cancer 2013; 108: 1432-9.
5. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt R P. Peritoneal car-cinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006; 243: 212-22.
6. Keettel WC, Elkins HG. Experience with radioactive colloidal gold in the treatment of ovarian carcinoma. Am J Obstet Gynecol 1956; 71: 553-68.
7. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
8. Noura S, Ohue M, Seki Y, Yano M, Ishikawa O, Kameyama M. Longterm prognostic value of conventional peritoneal lavage cytology in patients undergoing curative colorectal cancer resection. Dis Colon Rectum 2009; 52: 1312-20.
9. Mohan HM, O'Connor DB, O'Riordan JM, Winter DC. Prognostic significance of detection of microscopic peritoneal disease in colorectal cancer: a systematic review. Surg Oncol 2013; 22:e1-6.
10. Cotte E, Peyrat P, Piaton E, Chapuis F, Rivoire M, Glehen O, et al. Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multi-centre prospective study. Eur J Surg Oncol 2013; 39: 707-14.
11. Noura S, Ohue M, Shingai T, Kano S, Ohigashi H, Yano M, et al. Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings. Ann Surg Oncol 2011; 18: 396-404.
12. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008; 15: 2426-32.
13. Bosanquet DC, Harris DA, Evans MD, Beynon J. Systematic review and meta-analysis of intraoperative peritoneal lavage for colorectal cancer staging. Br J Surg 2013; 100: 853-62.
14. Altomare DF, Tedeschi M, Rotelli MT, Bocale D, Piscitelli D, Rinaldi M. Lack of prognostic role of pre- and postoperative peritoneal cytology and cytokeratin PCR-expression on local recurrence after curative anterior resection for mid-low rectal cancer. Updates Surg 2011; 63: 109-13.
15. Kowalewska M, Chechlinska M, Nowak R. Carcinoembryonic antigen and cytokeratin 20 in peritoneal cells of cancer patients: are we aware of what we are detecting by mRNA examination? Br J Cancer 2008; 98: 512-3.
16. Kristensen AT, Wiig JN, Larsen SG, Giercksky KE, Ekstrom PO. Molecular detection (k-ras) of exfoliated tumour cells in the pelvis is a prognostic factor after resection of rectal cancer? BMC Cancer 2008; 8: 213.
17. Lloyd JM, McIver CM, Stephenson SA, Hewett PJ, Rieger N, Hardingham JE. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin Cancer Res 2006; 12: 417-23.
18. Bosch B, Guller U, Schnider A, Maurer R, Harder F, Metzger U, et al. Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer. Br J Surg 2003; 90: 882-8.
19. Vogel I, Francksen H, Soeth E, Henne-Bruns D, Kremer B, Juhl H. The carcinoembryonic antigen and its prognostic impact on immu-nocytologically detected intraperitoneal colorectal cancer cells. Am J Surg 2001; 181: 188-93.
20. Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, Imrie C W, et al. Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol 2001; 54: 449-55.
21. Volmar KE, Vollmer RT, Routbort MJ, Creager AJ. Pancreatic and bile duct brushing cytology in 1000 cases: review of findings and comparison of preparation methods. Cancer 2006; 108: 231-8.
22. Abulafia O, Pezzullo JC, Sherer DM. Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol Oncol 2003; 90: 137-44.
23. Clayton AC, Bentz JS, Wasserman PG, Schwartz MR, Souers RJ, Chmara BA, et al. Comparison of ThinPrep preparations to other preparation types in gastrointestinal cytology: observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med 2010; 134: 1116-20.
24. Cabalag CS, Chan ST, Kaneko Y, Duong C P. A systematic review and meta-analysis of gastric cancer treatment in patients with positive peritoneal cytology. Gastric cancer 2014 Jun 3 [Epub]. Available from: http://dx.doi.org/10.1007/s10120-014-0388-5.
25. Simojoki M, Santala M, Vuopala S, Kauppila A. The prognostic value of peritoneal cytology in ovarian cancer. Eur J Gynaecol Oncol 1999; 20: 357-60.
26. Hompes D, Tiek J, Wolthuis A, Fieuws S, Penninckx F, Van Cutsem E, et al. HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? Ann Oncol 2012; 23: 3123-9.
27. Ripley RT, Davis JL, Kemp CD, Steinberg SM, Toomey MA, Avital I. Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases. Trials 2010; 11: 62.
28. Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010; 28: 63-8.
29. Smeenk RM, Verwaal VJ, Zoetmulder FA. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 2007; 94: 1408-14.
30. Stewart CJ, Hillery S, Platell C, Puppa G. Assessment of serosal invasion and criteria for the classification of pathological (p) T4 staging in colorectal carcinoma: confusions, controversies and criticisms. Cancers (Basel) 2011; 3: 164-81.